Financial Info

Financial Highlights  |  Ratios

Valuation P/E 19.99x   P/S 2.91x   P/B 3.04x   EPS 2083.40	Financial Strength Quick Ratio (MRQ) 1.61x   Current Ratio (MRQ) 3.40x   Total Debt/Equity (MRQ) 0.20x   Total Debt/Assets (MRQ) 0.17x	Operating Ratios Assets Turnover (TTM) 0.85x   Inventory Turnover (TTM) 1.77x   Receivables Turnover (TTM) 5.89x
Profitability Gross Margin (TTM) 36.79%   Operating Margin (TTM) 15.86%   EBIT Margin (TTM) 15.89%   Profit Margin (TTM) 12.61%	Management Effectiveness ROA (TTM) 10.76%   ROE (TTM) 13.10%   ROIC (TTM) 13.61%	Growth Rate Diluted EPS Growth (TTM) -61.46%   Sales Growth (TTM) 11.23%   Profit Growth (TTM) -10.96%   Asset Growth (TTM) 2.99%

MRQ: Most Recent Quarter    TTM: Trailing 12 Mon.    LFY: Last Fiscal Year

Imexpharm Corporation is a Vietnam-based pharmaceutical manufacturing and distributing company. The Company primarily manufactures, markets and trades pharmaceutical products, materials and equipment, including drugs, traditional medicine, cosmetics and drinks. It is also involved in the provision of packaging and warehousing services specialized for pharmaceutical storage. The Company manufactures more than...